Pasithea Therapeutics Corp.

United States of America


Create a watch for Pasithea Therapeutics Corp.
Total IP 9
Total IP Rank # 176,287
IP Activity Score 1.9/5.0    11
IP Activity Rank # 81,250
Stock Symbol KTTA (nasdaq)
ISIN US70261F1030
Market Cap. 3.600M  (USD)
Dominant Nice Class Medical, veterinary, hygienic an...

Patents

Trademarks

1 1
1 1
4 0
1
 
Last Patent 2025 - Anti-alpha5 integrin antibodies ...
First Patent 2022 - Alpha 5 beta 1 integrin binding ...
Last Trademark 2022 - PASITHEA
First Trademark 2021 - PASITHEA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Anti-alpha5 integrin antibodies and uses thereof. The present disclosure provides antibodies or a...
Invention Solid forms comprising (5r,6s)-10,11-difluoro-12-((2-fluoro-4-iodophenyl)amino)-5,6-dihydroxy-4,5...
Invention 10,11-difluoro-12-((2-fluoro-4-iodophenyl)amino)-5,6-dihydroxy-4,5,6,7-tetrahydro-1h-spiro[benzo[...
2023 Invention Anti-alpha5 integrin antibodies and uses thereof
2022 Invention Alpha 5 beta 1 integrin binding agents and uses thereof. The present disclosure provides α5β1 in...
G/S Pharmaceutical research and development; biotechnological research and development Medical servic...
2021 G/S Medical services; psychiatric services; pharmaceutical services.
G/S Pharmaceutical research and development; biotechnological research and development; pharmaceutica...